-+ 0.00%
-+ 0.00%
-+ 0.00%

Esperion Therapeutics announces shareholder meeting on merger agreement

PUBT·06/09/2026 20:02:08
Listen to the news
Esperion Therapeutics announces shareholder meeting on merger agreement
  • Esperion Therapeutics will hold a virtual special meeting of stockholders on July 8, 2026.
  • Stockholders will vote on adopting the merger agreement under which Essence MergerCo will merge into Esperion, leaving Esperion as a wholly owned unit of Essence Parent.
  • The deal has received German antitrust clearance, effective June 2, 2026.
  • Closing still hinges on remaining conditions, including US antitrust waiting periods and stockholder approval.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esperion Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-071814), on June 09, 2026, and is solely responsible for the information contained therein.